Embelia ribes extract reduces high fat diet and low dose streptozotocin-induced diabetic nephrotoxicity in rats

Nephropathy associated with type 2 diabetes is the single most common cause of end-stage renal disease. The aim of the present study was to evaluate the preventive effect of ethanolic extract of Embelia ribes fruit (EER) against high fat diet (HFD) and low dose streptozotocin (STZ)-induced diabetic nephrotoxicity in Wistar rats. HFD-fed and low dose STZ (35 mg/kg, i.p)-induced diabetic rats were treated with EER (100 and 200 mg/kg/day) for 21 days while continuing on HFD. Preventive effects of EER were demonstrated by significant reduction (p< 0.01) in body weight gain, fasting blood glucose, blood pressure, serum lactate dehydrogenase (LDH), creatinine, alkaline phosphatase (ALP), total cholesterol and triglyceride levels, while elevation in serum albumin and total protein levels. Insulin sensitizing effects were seen during oral glucose tolerance testing. Further, EER treatment significantly (p< 0.01) decreased the kidney thiobarbituric acid-reactive substance (TBARS) levels, while increasing the superoxide dismutase (SOD), catalase (CAT) and glutathione (GSH) levels in diabetic rats. Histological studies of kidney also supported the experimental findings. Taken together, our data suggest that EER attenuates renal injury in type 2 diabetic rats, possibly by improvement in glucose and lipid metabolism, enhancement of insulin sensitivity, blood pressure lowering, and inhibition of lipid peroxidation process.

[1]  H. Chaudhari,et al.  Preventive effect of embelin from embelia ribes on lipid metabolism and oxidative stress in high-fat diet-induced obesity in rats. , 2012, Planta medica.

[2]  H. Korashy,et al.  Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. , 2011, Chemico-biological interactions.

[3]  C. Arumughan,et al.  RP-HPLC-DAD method for the estimation of embelin as marker in Embelia ribes and its polyherbal formulations. , 2011, Biomedical chromatography : BMC.

[4]  Jie Yang,et al.  Antidiabetic and antioxidant effects of extracts from Potentilla discolor Bunge on diabetic rats induced by high fat diet and streptozotocin. , 2010, Journal of ethnopharmacology.

[5]  K. Srinivasan,et al.  Antidiabetic effect of Dodonaea viscosa aerial parts in high fat diet and low dose streptozotocin-induced type 2 diabetic rats: A mechanistic approach , 2010, Pharmaceutical biology.

[6]  M. Kuwahata,et al.  Dietary polyunsaturated fatty acids slow the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. , 2010, Nutrition research.

[7]  K. Trudeau,et al.  New Insights into Hyperglycemia-induced Molecular Changes in Microvascular Cells , 2010, Journal of dental research.

[8]  S. Ganti,et al.  Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions. , 2009, Pharmacological research.

[9]  U. Andersson,et al.  Isoforms of alanine aminotransferases in human tissues and serum--differential tissue expression using novel antibodies. , 2007, Archives of biochemistry and biophysics.

[10]  J. Imig,et al.  Obesity, Insulin Resistance, and Renal Function , 2007, Microcirculation.

[11]  U. Bhandari,et al.  Further Studies on Antioxidant Potential and Protection of Pancreatic β-Cells by Embelia ribes in Experimental Diabetes , 2007, Experimental diabetes research.

[12]  T. Kumai,et al.  Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy. , 2007, Life sciences.

[13]  Hernan Rincon-Choles,et al.  Kidney involvement in a nongenetic rat model of type 2 diabetes. , 2005, Kidney international.

[14]  P. Ramarao,et al.  Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. , 2005, Pharmacological research.

[15]  H. Kramer Screening for kidney disease in adults with diabetes mellitus: don't forget serum creatinine. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  M. Catalano,et al.  Oxidative stress impairs skeletal muscle repair in diabetic rats. , 2004, Diabetes.

[17]  C. Samaniego,et al.  Isoenzimas de fosfatasa alcalina en el suero de pacientes con insuficiencia renal , 2002 .

[18]  U. Bhandari,et al.  Effect of Ethanolic Extract of Embelia Ribes on Dyslipidemia in Diabetic Rats , 2002, International journal of experimental diabetes research.

[19]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[20]  M. Cooper,et al.  Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy , 2001, Diabetologia.

[21]  G. Remuzzi,et al.  Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment? , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  J. Vanherweghem Nephropathy and herbal medicine. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  K. H. Kim,et al.  Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. , 1999, Diabetes research and clinical practice.

[24]  B. Brenner,et al.  The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. , 1982, The American journal of medicine.

[25]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[26]  B. Mannervik,et al.  Purification and characterization of the flavoenzyme glutathione reductase from rat liver. , 1975, The Journal of biological chemistry.

[27]  S. Marklund,et al.  Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. , 1974, European journal of biochemistry.

[28]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[29]  N. Tabassum,et al.  DIABETIC NEPHROPATHY AND HERBAL MEDICINES , 2012 .

[30]  .. F. Shelar Embelin-An HPLC Method for Quantitative Estimation in Embelia ribes Burm , 2010 .

[31]  A. Krentz Antidiabetic Treatment in Obese Patients with Type 2 Diabetes - Effects of Medication on Bodyweight , 2006 .

[32]  P. Hall Prevention of Progression in Diabetic Nephropathy , 2006 .

[33]  G. Reaven Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome. , 2005, Cell metabolism.

[34]  M. Fernández-Conde,et al.  [Alkaline phosphatase isoenzymes in the serum of patients with renal insufficiency]. , 2002, Anales de medicina interna.

[35]  M. F. Weiss,et al.  Studies of renal injury III: lipid-induced nephropathy in type II diabetes. , 2000, Kidney international.